Multiple sclerosis (MS) is considered to be an autoimmune disease of the central nervous system (CNS) that in many patients first presents clinically as optic neuritis. The relationship of optic neuritis to MS is not well understood. We have generated novel T cell receptor (TCR) transgenic mice specific for myelin oligodendrocyte glycoprotein (MOG). MOG-specific transgenic T cells are not deleted nor tolerized and are functionally competent. A large proportion (>30%) of MOG-specific TCR transgenic mice spontaneously develop isolated optic neuritis without any clinical nor histological evidence of experimental autoimmune encephalomyelitis (EAE). Optic neuritis without EAE could also be induced in these mice by sensitization with suboptimal doses of MOG. The predilection of these mice to develop optic neuritis is associated with higher expression of MOG in the optic nerve than in the spinal cord. These results demonstrate that clinical manifestations of CNS autoimmune disease will vary depending on the identity of the target autoantigen and that MOG-specific T cell responses are involved in the genesis of isolated optic neuritis.
Skip Nav Destination
Article navigation
5 May 2003
Article|
May 05 2003
Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis
Estelle Bettelli,
Estelle Bettelli
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Maria Pagany,
Maria Pagany
2Department of Neuroimmunology, Max-Planck Institute for Neuroimmunology, 82152 Martinsried, Germany
Search for other works by this author on:
Howard L. Weiner,
Howard L. Weiner
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Christopher Linington,
Christopher Linington
2Department of Neuroimmunology, Max-Planck Institute for Neuroimmunology, 82152 Martinsried, Germany
3Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom
Search for other works by this author on:
Raymond A. Sobel,
Raymond A. Sobel
4Laboratory Service, Veterans Affairs Health Care System, Palo Alto, CA 94304
5Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305
Search for other works by this author on:
Vijay K. Kuchroo
Vijay K. Kuchroo
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Estelle Bettelli
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
Maria Pagany
2Department of Neuroimmunology, Max-Planck Institute for Neuroimmunology, 82152 Martinsried, Germany
Howard L. Weiner
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
Christopher Linington
2Department of Neuroimmunology, Max-Planck Institute for Neuroimmunology, 82152 Martinsried, Germany
3Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom
Raymond A. Sobel
4Laboratory Service, Veterans Affairs Health Care System, Palo Alto, CA 94304
5Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305
Vijay K. Kuchroo
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115
Address correspondence to Vijay K. Kuchroo, Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115. Phone: 617-525-5350; Fax: 617-525-5333; E-mail: [email protected]
*
Abbreviations used in this paper: CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; MBP, myelin basic protein; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; PLP, proteolipid protein; TBS, Tris-buffered saline.
Received:
September 11 2002
Revision Received:
February 20 2003
Accepted:
March 27 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (9): 1073–1081.
Article history
Received:
September 11 2002
Revision Received:
February 20 2003
Accepted:
March 27 2003
Citation
Estelle Bettelli, Maria Pagany, Howard L. Weiner, Christopher Linington, Raymond A. Sobel, Vijay K. Kuchroo; Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis . J Exp Med 5 May 2003; 197 (9): 1073–1081. doi: https://doi.org/10.1084/jem.20021603
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement